SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007715
Filing Date
2016-08-09
Accepted
2016-08-09 07:42:47
Documents
88
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amag-20160630x10q.htm 10-Q 2452471
2 EX-10.1 amag-20160630ex101e61d6d.htm EX-10.1 228760
3 EX-10.3 amag-20160630ex103d71659.htm EX-10.3 65367
4 EX-31.1 amag-20160630ex3114e2317.htm EX-31.1 19100
5 EX-31.2 amag-20160630ex3125a23a9.htm EX-31.2 19323
6 EX-32.1 amag-20160630ex321cc03f5.htm EX-32.1 9445
7 EX-32.2 amag-20160630ex322ee3831.htm EX-32.2 10221
  Complete submission text file 0001558370-16-007715.txt   11604091

Data Files

Seq Description Document Type Size
8 EX-101.INS amag-20160630.xml EX-101.INS 2879609
9 EX-101.SCH amag-20160630.xsd EX-101.SCH 68030
10 EX-101.CAL amag-20160630_cal.xml EX-101.CAL 106709
11 EX-101.DEF amag-20160630_def.xml EX-101.DEF 290273
12 EX-101.LAB amag-20160630_lab.xml EX-101.LAB 651064
13 EX-101.PRE amag-20160630_pre.xml EX-101.PRE 501659
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 161816071
SIC: 2834 Pharmaceutical Preparations